HomeCompareWMCNX vs JNJ

WMCNX vs JNJ: Dividend Comparison 2026

WMCNX yields 18.71% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 WMCNX wins by $36379154.42M in total portfolio value
10 years
WMCNX
WMCNX
● Live price
18.71%
Share price
$10.69
Annual div
$2.00
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$36379154.45M
Annual income
$36,009,410,109,696.20
Full WMCNX calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — WMCNX vs JNJ

📍 WMCNX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodWMCNXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, WMCNX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
WMCNX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

WMCNX
Annual income on $10K today (after 15% tax)
$1,590.27/yr
After 10yr DRIP, annual income (after tax)
$30,607,998,593,241.77/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, WMCNX beats the other by $30,607,998,589,255.79/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of WMCNX + JNJ for your $10,000?

WMCNX: 50%JNJ: 50%
100% JNJ50/50100% WMCNX
Portfolio after 10yr
$18189577.24M
Annual income
$18,004,705,057,192.80/yr
Blended yield
98.98%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

WMCNX
No analyst data
Altman Z
0.9
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

WMCNX buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricWMCNXJNJ
Forward yield18.71%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%28%
Portfolio after 10y$36379154.45M$30.3K
Annual income after 10y$36,009,410,109,696.20$4,689.40
Total dividends collected$36354525.16M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: WMCNX vs JNJ ($10,000, DRIP)

YearWMCNX PortfolioWMCNX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$14,442$3,741.81$10,592$272.30+$3.9KWMCNX
2$25,553$10,100.67$11,289$357.73+$14.3KWMCNX
3$60,748$33,405.94$12,123$472.89+$48.6KWMCNX
4$213,441$148,440.90$13,141$629.86+$200.3KWMCNX
5$1,203,250$974,867.78$14,408$846.81+$1.19MWMCNX
6$11,559,814$10,272,336.97$16,021$1,151.60+$11.54MWMCNX
7$196,832,508$184,463,506.10$18,122$1,588.22+$196.81MWMCNX
8$6,081,483,129$5,870,872,345.64$20,930$2,228.20+$6081.46MWMCNX
9$345,555,459,672$339,048,272,723.76$24,792$3,191.91+$345555.43MWMCNX
10$36,379,154,451,545$36,009,410,109,696.20$30,274$4,689.40+$36379154.42MWMCNX

WMCNX vs JNJ: Complete Analysis 2026

WMCNXStock

In pursuing the fund's investment objective, the Adviser employs dynamic, global macro-oriented asset and currency allocation strategies. These strategies attempt to exploit periodic market inefficiencies by taking long and short positions in various asset classes (e.g., equity and fixed-income) ("market-oriented strategies") and currencies ("currency-oriented strategies") with a view to profit from movements across and within such asset classes and currencies.

Full WMCNX Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this WMCNX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

WMCNX vs SCHDWMCNX vs JEPIWMCNX vs OWMCNX vs KOWMCNX vs MAINWMCNX vs ABBVWMCNX vs MRKWMCNX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.